Gout, bradycardia, and hypercholesterolemia after renal transplantation.
Approximately 17,000 solid organ transplantations are done annually in the United States. Increasingly, care of these patients will be provided by primary care physicians. In this report, we illustrate the complexity of common medical problems in a patient who had cellulitis and who had had a cadaveric renal transplantation 10 years earlier. Immunosuppressive therapy was cyclosporine (100 mg twice a day) and prednisone (10 mg once a day). The patient's hospital course was complicated by acute gout and symptomatic bradycardia. In both instances, usual treatment--full-dose indomethacin for gout and withholding verapamil for bradycardia--could have had significant interaction with the cyclosporine. At the time of discharge, a therapeutic plan for long-term management of hypercholesterolemia included possible drug interactions with cyclosporine. The potential for drug toxicity in the transplant patient necessitates careful monitoring of immunosuppressive drug levels. Ongoing communication with the transplant center is also needed.
Kelleher
S P
SP
Department of Internal Medicine, Texas Tech Medical Center, Amarillo 79106, USA.
Davis
W R
WR
Paraskevopoulos
N
N
D001919:Bradycardia / Q000150:complications* / Q000188:drug therapy; D003078:Colchicine / Q000627:therapeutic use; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D004347:Drug Interactions; D005260:Female; D006073:Gout / Q000150:complications* / Q000188:drug therapy; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications*; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use; D016030:Kidney Transplantation; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy
D006074:Gout Suppressants; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003078:Colchicine